Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew F Smith

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Eye & Contact Lens|April 13, 2012
Estimating the annual economic burden of illness caused by contact lens-associated corneal infiltrative events in the United StatesAndrew F Smith, Gary Orsborn
Current Opinion in Anaesthesiology|May 13, 2009
Communication between anaesthesiologists and patients: how are we doing it now and how can we improve?Alison Hool, Andrew F Smith
BMC Ophthalmology|November 27, 2009
Estimate of the direct and indirect annual cost of bacterial conjunctivitis in the United StatesAndrew F Smith, Curtis Waycaster
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Cost-effectiveness of olopatadine in seasonal allergic conjunctivitis treatmentAntoine Lafuma, Andrew F Smith
The Cochrane Database of Systematic Reviews|October 13, 2009
Premedication for anxiety in adult day surgeryKevin J Walker, Andrew F Smith
Paediatric Anaesthesia|November 9, 2010
An analysis of critical incidents relevant to pediatric anesthesia reported to the UK National Reporting and Learning System, 2006-2008Andrew I MacLennan, Andrew F Smith
Psychology, Health & Medicine|January 11, 2011
Risking safety or safely risking? Healthcare professionals' understanding of risk-taking in everyday workKonstantinos Arfanis, James Shillito, Andrew F Smith
Journal of Public Health Research|August 30, 2014
Tuberculosis in quebec: a review of trendsAlexander Klotz, Abdoulaye Harouna, Andrew F Smith
BMC Public Health|April 30, 2013
Forecast analysis of the incidence of tuberculosis in the province of QuebecAlexander Klotz, Abdoulaye Harouna, Andrew F Smith
American Journal of Ophthalmology|August 8, 2009
A systematic analysis of the off-label use of bevacizumab for severe retinopathy of prematurityJonathan A Micieli, Michael Surkont, Andrew F Smith
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Eye & Contact Lens|April 13, 2012
Estimating the annual economic burden of illness caused by contact lens-associated corneal infiltrative events in the United StatesAndrew F Smith, Gary Orsborn
Current Opinion in Anaesthesiology|May 13, 2009
Communication between anaesthesiologists and patients: how are we doing it now and how can we improve?Alison Hool, Andrew F Smith
BMC Ophthalmology|November 27, 2009
Estimate of the direct and indirect annual cost of bacterial conjunctivitis in the United StatesAndrew F Smith, Curtis Waycaster
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Cost-effectiveness of olopatadine in seasonal allergic conjunctivitis treatmentAntoine Lafuma, Andrew F Smith
The Cochrane Database of Systematic Reviews|October 13, 2009
Premedication for anxiety in adult day surgeryKevin J Walker, Andrew F Smith
Paediatric Anaesthesia|November 9, 2010
An analysis of critical incidents relevant to pediatric anesthesia reported to the UK National Reporting and Learning System, 2006-2008Andrew I MacLennan, Andrew F Smith
Psychology, Health & Medicine|January 11, 2011
Risking safety or safely risking? Healthcare professionals' understanding of risk-taking in everyday workKonstantinos Arfanis, James Shillito, Andrew F Smith
Journal of Public Health Research|August 30, 2014
Tuberculosis in quebec: a review of trendsAlexander Klotz, Abdoulaye Harouna, Andrew F Smith
BMC Public Health|April 30, 2013
Forecast analysis of the incidence of tuberculosis in the province of QuebecAlexander Klotz, Abdoulaye Harouna, Andrew F Smith
American Journal of Ophthalmology|August 8, 2009
A systematic analysis of the off-label use of bevacizumab for severe retinopathy of prematurityJonathan A Micieli, Michael Surkont, Andrew F Smith
Pageof 8